Browse drugs

…ctives To evaluate the efficacy and safety of low concentration atropine eye drops for reducing progression of myopia in children in the…

…ls (RCTs) including children ≤16 years with myopia who received atropine treatment. Thirty-four RCTs with ≥12 months of follow-up were i…

…e were no significant differences in myopia progression between atropine and placebo treated eyes, there were trends towards less myopic…

…d controlled trials (figure 1), most of which showed that 0.01% atropine eyedrops have some myopia control effect. However, the efficacy…

… evidence that RLRL, 0.01% atropine, Ortho-k and 0.01% atropine+Ortho-k are all effective in suppressing myopia progress. In terms of l…

…e effects from the use of pharmacological agents dobutamine and atropine. There is a need for strategies to mitigate the risk of side ef…

…s; median SER –5.0 D) was conducted. Patients were treated with 0.05% atropine unit-dose eye drops prepared weekly under class A cleanroom con…

… were achieved. Repeat conduction indices were measured, and an atropine test was performed before procedure conclusion. Amongst the con…

….060 5.16 ± 0.012 Abstract 3PC-005 Tabel 3Average osmolality of atropine sulfate eye dropsBatch 4-week in use (mosm/kgH2O) 14-week stability (mo…

… 0.01% low-dose atropine for 24 months (0.01%) or 0.1% low-dose atropine for 6 months, then 0.01% for 18 months (0.1% loading dose) or p…

…on of left and right atrial ganglionated plexi, with adjunctive atropine testing and vagal stimulation. Three female patients (mean age …

…c children (spherical equivalent (SER) −0.49 to +1.0D) from the Atropine Treatment of Myopia (ATOM3) study were analysed. Cycloplegic SE…